| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 08/16/2011 | US7998973 Tivozanib and temsirolimus in combination |
| 08/16/2011 | CA2521695C Method for producing 3-substituted 2-chloro-5-fluoro-pyridine or its salt |
| 08/16/2011 | CA2369270C Camptothecin analogs and methods of preparation thereof |
| 08/11/2011 | WO2011096386A1 Smart window employing organic/metallic hybrid polymer, method for manufacturing smart window, and smart window system |
| 08/11/2011 | WO2011095997A1 Benzamide compounds as glucokinase activators and their pharmaceutical application |
| 08/11/2011 | WO2011095593A1 Iodo precursor for a pet imaging agent of amyloid plaques |
| 08/11/2011 | WO2011095533A1 Oxalamide derivative as umami flavouring agent |
| 08/11/2011 | WO2011095450A1 Cyclohexyl amide derivatives as crf receptor antagonists |
| 08/11/2011 | WO2011095027A1 Pyridyl cyanoguanidine derivatives |
| 08/11/2011 | WO2011094953A1 Compounds for the treatment and prevention of influenza |
| 08/11/2011 | WO2011018170A3 Pesticidal carboxamides |
| 08/11/2011 | WO2011012271A3 Method and substances for preparation of n-substituted pyridinium compounds |
| 08/11/2011 | WO2011012269A3 Method and substances for preparation of n-substituted pyridinium compounds |
| 08/11/2011 | WO2010143170A3 Compounds useful for treating premature aging and in particular progeria |
| 08/11/2011 | US20110196149 Fluoridation method |
| 08/11/2011 | US20110195999 Novel antifungal agent containing heterocyclic compound |
| 08/11/2011 | US20110195993 Ppar agonist compounds, preparation and uses |
| 08/11/2011 | US20110195979 Compounds for the treatment and prevention of influenza |
| 08/11/2011 | US20110195940 Protease Inhibitors Having Enhanced Features |
| 08/11/2011 | US20110195939 Antitumor properties of no modified protease inhibitors |
| 08/11/2011 | US20110195028 Magnetic resonance imaging and/or spectroscopy contrast agents and methods of use thereof |
| 08/11/2011 | US20110193022 Five-ring liquid crystal compound having a nitrogen-containing heterocyclic ring, liquid crystal composition and liquid crystal display device |
| 08/11/2011 | DE102011003508A1 Bipyridyl-substituierte Anthracen-Derivate und ihre Verwendung in organischen elektrolumineszenten Anordnungen Bipyridyl-substituted anthracene derivatives and their use in organic electroluminescent devices |
| 08/10/2011 | EP2354126A1 Heteroaryl sulfonamides and CCR2 |
| 08/10/2011 | EP2354120A1 Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof |
| 08/10/2011 | EP2352723A2 Halogen-substituted compounds used as pesticides |
| 08/10/2011 | CN102149714A Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 08/10/2011 | CN102149681A Piperazine derivatives for binding and imaging amyloid plaques and their use |
| 08/10/2011 | CN102149677A Bi-aryl aminotetralines |
| 08/10/2011 | CN102149669A Process for producing carbonyloxy compound |
| 08/10/2011 | CN102146090A Luminescent material prepared from dianthracene compounds substituted by aromatic rings |
| 08/10/2011 | CN102146055A N-alkylpyridine-L-proline salt chiral ionic liquid and preparation method thereof |
| 08/10/2011 | CN102146008A Organic solvent-free synthesis method of aromatic amine compounds |
| 08/10/2011 | CN102146007A Method for preparing secondary amine and tertiary amine |
| 08/10/2011 | CN101812699B Method for simultaneously preparing tetrachloropyridine and diglycolic acid in cathode and anode chambers |
| 08/09/2011 | US7994333 Methods and compositions for selectin inhibition |
| 08/09/2011 | US7994177 Therapeutic agents useful for treating pain |
| 08/09/2011 | US7994142 Agents containing folic acid, vitamin B6 and vitamin B12, and the use thereof |
| 08/09/2011 | US7994093 Heterocyclocarboxamide derivatives |
| 08/09/2011 | US7993494 Method for manufacturing triarylpyrazine derivative |
| 08/09/2011 | CA2662766C Diaryl ether derivatives and uses thereof |
| 08/09/2011 | CA2572208C 3-carbamoyl-2-pyridone derivative |
| 08/09/2011 | CA2512000C Selective estrogen receptor modulator |
| 08/09/2011 | CA2451151C Carbamates of 2-heterocyclic-1,2-ethanediols |
| 08/09/2011 | CA2431083C Inflammatory cytokine release inhibitor |
| 08/09/2011 | CA2428039C Serotonergic agents |
| 08/04/2011 | WO2011093524A1 Di - substituted pyridine derivatives as anticancers |
| 08/04/2011 | WO2011093256A1 Method for producing 4-chloropyridine-2-carboxylic acid chloride |
| 08/04/2011 | WO2011092663A2 4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-n2-methylpyridine-2-carboxamide dimethyl sulphoxide solvate |
| 08/04/2011 | WO2011092618A1 Method for the preparation of fluazinam |
| 08/04/2011 | WO2011092284A1 Novel amino acid derivatives and their use as gpr43 receptor modulators |
| 08/04/2011 | WO2011023756A4 Organophosphorus compounds based on tetraphenol (tp)-substituted structures |
| 08/04/2011 | WO2010108856A8 Leukotriene b4 inhibitors |
| 08/04/2011 | US20110190505 Iodonium Cyclophanes for SECURE Arene Functionalization |
| 08/04/2011 | US20110190354 Glycyrrhetinic acid derivative and use thereof |
| 08/04/2011 | US20110190346 Diphenyl Substituted Alkanes as Flap Inhibitors |
| 08/04/2011 | US20110190330 Spirocyclic gpr40 modulators |
| 08/04/2011 | US20110190325 Compounds, their syntheses, and thier uses |
| 08/04/2011 | US20110190295 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling |
| 08/04/2011 | US20110190283 Fab I Inhibitors |
| 08/04/2011 | US20110190282 Novel vegf-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 08/04/2011 | US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor |
| 08/04/2011 | US20110190227 Antagonists of Prostaglandin D2 Receptors |
| 08/04/2011 | US20110190137 Method to inhibit ethylene responses in plants |
| 08/04/2011 | DE102010006854A1 Verfahren zur Gasphasenoxidation von Kohlenwasserstoffen A process for the gas phase oxidation of hydrocarbons |
| 08/04/2011 | CA2788146A1 Sorafenib dimethtyl sulphoxide solvate |
| 08/04/2011 | CA2788073A1 Di-substituted pyridine derivatives as anticancers |
| 08/03/2011 | EP2351741A1 Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element |
| 08/03/2011 | EP2351740A1 Insecticidal composition comprising N-substituted (6-haloalkylpyridin-3-YL)alkyl sulfoximines |
| 08/03/2011 | EP2351739A1 The 2-(4-substituted phenylamino) polysubstituted pyridine compounds as the inhibitors of non-nucleoside hiv reverse transcriptase, praparation methods and uses thereof |
| 08/03/2011 | EP2350311A1 Diacylglycerol acyltransferase inhibitors |
| 08/03/2011 | EP2350010A1 Isonicotinamide orexin receptor antagonists |
| 08/03/2011 | EP2350009A1 Sulfonate salts of flupirtine |
| 08/03/2011 | EP2350008A1 Method for the preparation of functionalized trihalomethoxy substituted pyridines |
| 08/03/2011 | EP2350007A1 Heterocyclic antiviral arylpyridone derivatives |
| 08/03/2011 | EP2350006A1 Compounds for inflammation and immune-related uses |
| 08/03/2011 | EP2350005A1 N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275)polymorph b |
| 08/03/2011 | EP2350000A1 Piperazine derivatives for binding and imaging amyloid plaques and their use |
| 08/03/2011 | EP2349999A1 Allosteric protein kinase modulators |
| 08/03/2011 | EP2349982A1 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition |
| 08/03/2011 | EP2349977A2 Fluorination of aromatic ring systems |
| 08/03/2011 | EP2349484A2 Heteroaryl derivatives as dgat1 inhibitors |
| 08/03/2011 | CN1890218B Tubulin inhibitors |
| 08/03/2011 | CN1875002B Phenyl derivatives as PPAR agonists |
| 08/03/2011 | CN102143948A Process for preparing (s)-(-)-felodipine |
| 08/03/2011 | CN102143942A Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors |
| 08/03/2011 | CN102143940A Cyclohexyl amide derivatives and their use as CRF-1 receptor antagonists |
| 08/03/2011 | CN102143935A Method for producing aminobiphenylene |
| 08/03/2011 | CN102143747A New pyridine derivatives as leptin receptor modulator mimetics |
| 08/03/2011 | CN102140093A Pyridine amide derivatives, preparation method thereof and application thereof in medicines |
| 08/03/2011 | CN102140077A Flupirtine A crystal form and preparation method thereof |
| 08/03/2011 | CN102140064A Compounds for the treatment of metabolic disorders |
| 08/03/2011 | CN102139197A Method for preparing modified micro granules |
| 08/03/2011 | CN101723889B Method for synthesizing 6-chloropyridine-3-carbonyl chloride |
| 08/03/2011 | CN101698659B Synthesis method of 2-pyridine formaldoxime |
| 08/03/2011 | CN101648907B Purifying method of 2-chloromethyl-4-methoxyl-3,5-dimethylpyridine chloride |
| 08/03/2011 | CN101648904B Synthesis method of 2,3-difluoro-5-chloropyridine |
| 08/03/2011 | CN101582487B Organic electroluminescent device and display unit |
| 08/03/2011 | CN101160287B 吡啶基非芳香族含氮杂环-1-羧酸酯衍生物 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative |
| 08/03/2011 | CN101065360B Thermodynamically stable form of BAY 43-9006 tosylate |